News | Radiopharmaceuticals and Tracers

NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) for its accelerator method of producing the medical radioisotope molybdenum-99 (Mo-99). The addition brings the total funding for the new method, in development by subisidiary NorthStar Medical Radioisotopes, to $11.1 million.

Home January 17, 2017
Home
News | Cardiovascular Business

ECRI Institute announced a new mergers and acquisitions service that empowers new hospital alliances to control their spending and plan for the future by eliminating waste and redundancy in medical-surgical supplies and capital medical equipment.

Home January 17, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

Warfarin is a commonly prescribed blood thinner used to prevent harmful blood clots. However, the drug requires frequent monitoring, daily dosing and can result in serious negative effects when mixed with vitamin K, a vitamin commonly found in vegetables such as lettuce or broccoli. Now, a new study from University of Missouri Health Care has found that using electronic health records (EHR) can improve the care patients receive after they leave the hospital and eliminate potential confusion among care providers and pharmacists.

Home January 17, 2017
Home
News | Heart Valve Technology

Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the CoreValve Evolut R 34 mm valve — the largest sized transcatheter aortic valve implantation (TAVI) system available in Europe. The new Evolut R 34 mm valve is approved for severe aortic stenosis patients who are at intermediate, high or extreme risk for surgery with an annulus size ranging from 26-30 mm. This large valve segment is estimated to account for approximately 20-25 percent of the eligible European TAVI patient population. Previously, some of these patients were unable to receive a TAVI due to the larger size of their native diseased aortic valve.

Home January 17, 2017
Home
News | Implantable Cardioverter Defibrillator (ICD)

Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years, according to a new study in the Journal of the American College of Cardiology. This is a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation.

Home January 17, 2017
Home
News | Cardiovascular Information Systems (CVIS)

Lumedx Corp. recently announced that it has implemented Phase 1 of a long-term, multiphase cardiovascular information system (CVIS) project with Baylor Scott & White Health.

Home January 17, 2017
Home
News | Cardiac Diagnostics

Investigators at the University of Utah have identified distinct differences in the hearts of advanced heart failure patients who have defied the odds and showed signs of recovery from the disease. Published online in the journal Circulation, the new findings could help clinicians identify the best candidates for cardiac recovery therapies.

Home January 17, 2017
Home
Technology | Blood Pressure Monitor

The new SunTech Oscar 2 24-hour ambulatory blood pressure monitoring system is now available with the True24 ABPM Patient Diary mobile app, which links to the Oscar 2 via Bluetooth. The True24 app provides a tutorial on ABPM, and prompts the patient to enter information about their activity, posture or any symptoms experienced during a physician-prescribed ABPM study. This diary information helps clinicians interpret the ambulatory blood pressure study data to make well-informed hypertension treatment decisions.

Home January 17, 2017
Home
MD Buyline, James Laskaris, four medical technology innovations, very near future
Feature | Cardiac Imaging

James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on new medical technology innovations that might be just months or a few years away.

Home January 17, 2017
Home
Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent
Feature | Stents Bioresorbable | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers ...

Home January 17, 2017
Home
News | Information Technology

Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced Medical Technologies, that identifies 18 technologies that will impact healthcare paradigms by 2025.

Home January 16, 2017
Home
News | EP Mapping and Imaging Systems

January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac ...

Home January 16, 2017
Home
Arterys, Cardiac MRI, cardiac MRI advances
Feature | Cardiac Imaging | Dave Fornell

Each year imaging system manufacturers use the Radiological Society of North America (RSNA) meeting at the end of the ...

Home January 16, 2017
Home
News | Heart Valve Technology

January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the ...

Home January 16, 2017
Home
News | Leads Implantable Devices

BioTrace Medical Inc. announced in December the first commercial use of the company’s Tempo Temporary Pacing Lead since U.S. Food and Drug Administration (FDA) 510(k) clearance in October 2016.

Home January 13, 2017
Home
Subscribe Now